NR4A2 and urinary bladder carcinoma: For instance, NR4A2 exhibits oncogenic functions in cervical, prostate, and colon cancers by promoting malignant transformation and refraining intrinsic apoptosis [52, 53], while acting as a tumor suppressor in bladder cancer by eliciting cell apoptosis [54].